Beispiel: Heart Attack

Suchen Sie in klinischen Studien nach: Halofuginone

Insgesamt 5 ergebnisse

NCT00064142

Abgeschlossen

Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma

Bedingungen: AIDS-related Kaposi Sarcoma; Recurrent Kaposi Sarcoma
NCT00027677

Abgeschlossen

Halofuginone Hydrobromide in Treating Patients With Progressive Advanced Solid Tumors

Bedingungen: Unspecified Adult Solid Tumor, Protocol Specific
NCT02525302

Beendet

HT-100 Long-term Study in DMD Patients Who Completed HALO-DMD-02

Bedingungen: Duchenne Muscular Dystrophy
NCT01847573

Beendet

Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy

Bedingungen: Duchenne Muscular Dystrophy
NCT01978366

Beendet

Open Label Extension Study of HT-100 in Patients With DMD

Bedingungen: Duchenne Muscular Dystrophy